Canada markets closed

Avenue Therapeutics, Inc. (ATXI)

NasdaqCM - NasdaqCM Delayed Price. Currency in USD
Add to watchlist
6.20-2.58 (-29.35%)
At close: 04:00PM EDT
6.26 +0.06 (+0.97%)
After hours: 07:57PM EDT
Currency in USD

Valuation Measures4

Market Cap (intraday) 3.66M
Enterprise Value 1.88M
Trailing P/E N/A
Forward P/E 17.99
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)N/A
Price/Book (mrq)2.31
Enterprise Value/Revenue N/A
Enterprise Value/EBITDA -0.18

Trading Information

Stock Price History

Beta (5Y Monthly) -0.26
52-Week Change 3-91.60%
S&P500 52-Week Change 322.36%
52 Week High 393.75
52 Week Low 35.78
50-Day Moving Average 311.09
200-Day Moving Average 331.26

Share Statistics

Avg Vol (3 month) 327.4k
Avg Vol (10 day) 361.2k
Shares Outstanding 5590.14k
Implied Shares Outstanding 644.26M
Float 8520.33k
% Held by Insiders 111.81%
% Held by Institutions 12.79%
Shares Short (Apr 15, 2024) 42.58k
Short Ratio (Apr 15, 2024) 40.19
Short % of Float (Apr 15, 2024) 40.44%
Short % of Shares Outstanding (Apr 15, 2024) 40.44%
Shares Short (prior month Mar 15, 2024) 44.18k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 21:75
Last Split Date 3Apr 26, 2024

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2023
Most Recent Quarter (mrq)Dec 31, 2023

Profitability

Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)-209.03%
Return on Equity (ttm)-535.10%

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
EBITDA N/A
Net Income Avi to Common (ttm)-10.38M
Diluted EPS (ttm)-73.50
Quarterly Earnings Growth (yoy)11.30%

Balance Sheet

Total Cash (mrq)1.78M
Total Cash Per Share (mrq)3.02
Total Debt (mrq)N/A
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)1.55
Book Value Per Share (mrq)4.64

Cash Flow Statement

Operating Cash Flow (ttm)-9.45M
Levered Free Cash Flow (ttm)-13.49M